NCT00544414 Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck Cancer Status COMPLETED Phase PHASE2
NCT00544362 Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgery Status COMPLETED Phase PHASE1/PHASE2
NCT00544349 Leucovorin, Fluorouracil, Cetuximab, and Oxaliplatin in Treating Patients With Stage IV Colorectal Cancer and Liver Metastases That Cannot Be Removed by Surgery Status COMPLETED Phase PHASE2
NCT00544011 Bevacizumab and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Status UNKNOWN Phase PHASE2
NCT00541125 G-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00541112 Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery Status TERMINATED Phase PHASE2
NCT00537823 Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement Status TERMINATED Phase PHASE2
NCT00537121 Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer Status COMPLETED Phase PHASE1
NCT00533936 Trastuzumab or Observation After Combination Chemotherapy and Trastuzumab in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer Status UNKNOWN Phase PHASE2
NCT00524186 Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer Status TERMINATED Phase PHASE1
NCT00514020 Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer Status COMPLETED Phase PHASE2
NCT00513266 Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery Status UNKNOWN Phase PHASE2
NCT00507585 Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and Avastin Status COMPLETED Phase PHASE1
NCT00499369 Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy Status TERMINATED Phase PHASE3
NCT00498953 Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx Status COMPLETED Phase PHASE1/PHASE2
NCT00492999 Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT00482222 Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer Status UNKNOWN Phase PHASE3
NCT00471484 Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery Status UNKNOWN Phase PHASE2
NCT00467142 Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery Status COMPLETED Phase PHASE2
NCT00462735 Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer Status COMPLETED Phase PHASE2